Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Shares of Wockhardt are higher by 5% on January 3 after Indian drug regulator approved oral antibiotic for the treatment of Pneumonia, the company informed in an exchange filing. Central Drugs ...

Wockhardt’s shares surged 9.5% to ₹1,583 after regulatory approval for its antibiotic Miqnaf for pneumonia treatment. The ...

Wockhardt's novel antibiotic Miqnaf approved for CABP treatment, offering a promising monotherapy option for MDR pathogens.

HealthDay News — Many general practitioners prescribe antibiotics for suspected community-acquired pneumonia (CAP) even when chest radiograph (CR) results are negative, according to a study published ...

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new ...

usually necessitates a more prolonged course of intravenous antibiotics as compared to pneumonia caused by the less virulent and more antibiotic sensitive Mycoplasma pneumoniae. Antibiotic ...

Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can leave people feeling short of breath. With walking pneumonia, any ...

Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, ...

Symptoms include colds, coughing, diarrhea, fevers, and breathing difficulties. In previous eras, pneumonia was often a killing disease but the use of antibiotics in the twentieth century dramatically ...

The severity of pneumonia was relatively low as evidenced ... guidelines aimed at both early conversion from intravenous antibiotics to oral therapy and early hospital discharge are feasible ...

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores ...